One of the directions of R&D is the development of new methods and technologies for fundamental and applied research. The development program includes the following services:
TECHNOLOGY DEVELOPMENT OF BIOPHARMACEUTICAL SUBSTANCES AND STERILE F&F PRODUCTION (IBH32);
BIOIMAGING (IBH33);
ADENOASSOCIATED AND LENTIVIRAL VECTORS (IBH34);
ANTIBIOTIC AND PROBIOTIC ULTRAHIGH-THROUGHPUT SCREENING SERVICE (IBH35);
RESEARCH AND CLINICAL APPLICATIONS ON AN OPEN-ARCHITECTURE OPTICAL BIOIMAGING MODULAR PLATFORM (IBH33);
PRE-CLINICAL TRIALS (STANDARDIZED CERTIFIED METHODS) (IBH36, IBH36 continuance).
AS PART OF THE CREATION OF INNOVATIVE MEDICINES, TECHNOLOGIES AND MEDICAL PRODUCTS WITH INTERNATIONAL STANDARDS GMP IBСH RAS DEVELOPS FINISHED PHARMACEUTICAL SUBSTANCES AND FINISHED DOSAGE FORMS FOR RELEVANT FIELDS OF MEDICINE.
Подробнее
